Enlivex receives Danish approval for knee osteoarthritis trial

April 21, 2026 8:31 AM

Enlivex Ltd. (NASDAQ: ENLV) received Clinical Trial Application approval from the Danish Medicines Agency for its Phase 2b trial of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found